Skip to main content

Table 2 Outcome of the patients

From: Delirium and encephalopathy in severe COVID-19: a cohort analysis of ICU patients

  All patients (n = 140) No delirium and normal neurological examination (N = 22) Delirium and/or abnormal neurological examination (N = 118) p
Invasive mechanical ventilation
 Duration (days)—median [IQR] 13 [9; 23] 9 [5; 17] 14 [10; 25] 0.011
 Auto-extubation with immediate reintubation—n (%) 11 (7.9) 0 (0.0) 11 (9.3) 0.211
ICU stay
 ICU mortality—n (%) 21 (15.0) 2 (9.1) 19 (16.1) 0.634
 Length of stay (days)—median [IQR] 15 [10; 25] 10 [6; 21] 15 [11; 25] 0.017
Sedative treatments
 Midazolam—n (%) 121 (86.4) 18 (81.8) 103 (87.3) 0.691
 Midazolam (days)—median [IQR] 6 [3; 12] 4 [1; 9] 7 [4; 12] 0.095
 Sufentanil—n (%) 138 (98.6) 20 (90.9) 118 (100) 0.047
 Sufentanil—median [IQR] 10 [5; 15] 6 [1; 9] 11 [6; 16] 0.004
 Propofol—n (%) 83 (59.3) 8 (36.4) 75 (63.6) 0.017
 Propofol—median [IQR] 2 [0; 6] 0 [0; 3] 2 [0; 7] 0.027